ACTH (1-39)

ACTH (1-39) is the complete 39-amino-acid sequence of adrenocorticotropic hormone, a peptide hormone characteristically produced by the anterior pituitary. In laboratory settings it is examined as a principal ligand of the hypothalamic-pituitary-adrenal axis. Researchers employ the full-length peptide to probe adrenal cortical responses and the molecular events that couple pituitary signals to steroidogenic output. Its defined primary structure makes it a reference standard for comparing truncated ACTH analogs in controlled experimental systems.

ACTH (1-39) engages the melanocortin-2 receptor (MC2R), a G-protein-coupled receptor expressed on adrenal cortical cells. Receptor occupancy elevates intracellular cyclic AMP, activates protein kinase A, and drives transcriptional upregulation of steroidogenic enzymes. Laboratory models track this cascade through measurements of second-messenger accumulation and subsequent corticosteroid biosynthetic activity. Accessory proteins such as MRAP are also studied for their influence on MC2R trafficking and signaling fidelity.

Investigators use ACTH (1-39) to dissect melanocortin-2 receptor signaling pathways and the enzymatic steps of cortisol and corticosteroid synthesis within adrenal cell cultures and tissue explants. Parallel work examines HPA-axis feedback loops by quantifying how the peptide modulates hypothalamic and pituitary peptide release in isolated systems. Additional studies address receptor desensitization, ligand binding kinetics, and the structural determinants required for full agonist activity. These approaches remain confined to in-vitro and laboratory research models.

Controlled experiments have established that ACTH (1-39) elicits robust, concentration-dependent stimulation of corticosteroid production via MC2R-cAMP signaling in adrenal preparations. Structure-function analyses confirm that the intact 39-residue sequence supports high-affinity receptor interaction and full agonist efficacy relative to shorter fragments. Work in endocrine cell lines has further mapped the temporal profile of steroidogenic enzyme induction following peptide exposure. Collectively these observations refine understanding of adrenal steroidogenesis under defined laboratory conditions.

ACTH (1-39) is supplied exclusively for in-vitro and laboratory research applications. Investigators typically reconstitute the lyophilized peptide in appropriate aqueous buffers under sterile conditions and store aliquots at low temperature to preserve integrity. Experimental protocols should incorporate vehicle controls and receptor antagonists when dissecting MC2R-dependent effects. All handling must adhere to institutional biosafety guidelines for peptide reagents; the material is not intended for any form of administration outside controlled research environments.